Rockwell Medical Technologies, Inc. (RMTI)

[DorseyE]

Little-Known Drug Developer is on the Brink of Getting FDA Approved
The condition is… anemia.

It’s an iron deficiency disorder—often associated with diabetes mellitus or Type 2—that affects more than 2.8 million Americans1 and over 1.62 billion people worldwide5.

And with the growing prevalence of diabetes, which is projected to increase by 54% to more than 54.9 million Americans between 2015 and 2030, and increased societal costs related to the disease to increase at roughly the same rate to more than $622 billion by 20306… this new drug if approved is clearly very needed.

It’s time to take an in-depth look at a company possibly on the cusp of a major drug approval, that’s here to protect those with anemia and kidney disease.

https://microsmallcap.com/rockwell-medical-inc/RMTI-1/biotech-stock-pick/LP-G1